In humans vitamin A (retinol) is required for the appropriate regulation of the growth and differentiation of many types of cells, including the epithelial cells of the prostate. Data in humans and in animal models indicate that vitamin A (retinol) and related compounds (retinoids) may play important roles in the development, prevention and therapy of human prostate cancer, in part by regulating prostate epithelial cell growth and differentiation. We propose experiments aimed at understanding the molecular basis for the regulation of vitamin A metabolism in human and murine epithelial cells. We have preliminary data that vitamin A is esterified in normal epithelial cells and that this esterification is positively regulated at the transcriptional level by retinoic acid (RA), a biologically active metabolite of vitamin A. In carcinoma cells, including human prostate cancer cells, esterification of vitamin A is greatly reduced; this leads to a state of vitamin A deficiency in the tumor cells. We plan to delineate the molecular basis for the aberrant vitamin A metabolism in cultured human prostate cancer cell lines by employing molecular biological approaches, enzymatic analyses, and human prostate tumor xenograft models in athymic mice. In addition, we plan to utilize the transgenic adenocarcinoma mouse prostate (TRAMP) model, in which expression of the SV4o T Antigen driven by the probasin promoter leads to the development of all stages of prostate cancer from initiation to metastases, to ascertain if vitamin A metabolism becomes altered as the prostate epithelial cells in the TRAMP mice progress from normal to tumorigenic. Genes encoding enzymes involved in vitamin A metabolism will be ectopically expressed in the prostate epithelium of TRAMP mice to determine if this expression alters the progression of prostate cancer and/or markers of differentiation in the TRAMP model. These proposed studies will allow us to explore the role of vitamin A and retinyl ester levels in the etiology of prostate cancer, and to gain a better understanding of the involvement of retinoids in the development and progression of prostate cancer. Moreover, the experiments proposed in this application will clarify the potential use of retinoids as a therapeutic strategy to treat patients with prostate cancer, the second most common cause of cancer deaths in American males, and these studies may also lead to the identification of new therapeutic agents which stimulate vitamin A esterification for the treatment of various stages of prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA097543-01A1S1
Application #
7125663
Study Section
Chemo/Dietary Prevention Study Section (CDP)
Program Officer
Ogunbiyi, Peter
Project Start
2005-03-01
Project End
2010-02-28
Budget Start
2005-09-01
Budget End
2006-02-28
Support Year
1
Fiscal Year
2005
Total Cost
$48,581
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Larsson, R; Mongan, N P; Johansson, M et al. (2011) Clinical trial update and novel therapeutic approaches for metastatic prostate cancer. Curr Med Chem 18:4440-53
Lee, Mi-Young; Lu, Ailan; Gudas, Lorraine J (2010) Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells. J Cell Physiol 224:17-27
Wang, Rui; Wang, Guoqing; Ricard, Megan J et al. (2010) Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals. Chest 138:1402-10
Scotland, Kymora B; Chen, Siming; Sylvester, Renia et al. (2009) Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation. Dev Dyn 238:1863-77
Touma, Sue Ellen; Perner, Sven; Rubin, Mark A et al. (2009) Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model. Biochem Pharmacol 78:1127-38
Kashyap, Vasundhra; Rezende, Naira C; Scotland, Kymora B et al. (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18:1093-108
Cai, Kun; Gudas, Lorraine J (2009) Retinoic acid receptors and GATA transcription factors activate the transcription of the human lecithin:retinol acyltransferase gene. Int J Biochem Cell Biol 41:546-53
Tavares, Trisha S; Nanus, David; Yang, Ximing J et al. (2008) Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment. Cancer Biol Ther 7:1607-18
Liu, Limin; Tang, Xiao-Han; Gudas, Lorraine J (2008) Homeostasis of retinol in lecithin: retinol acyltransferase gene knockout mice fed a high retinol diet. Biochem Pharmacol 75:2316-24
Adams, Denise M; Zhou, Tianni; Berg, Stacey L et al. (2008) Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children's Oncology Group study. Pediatr Blood Cancer 50:549-53

Showing the most recent 10 out of 15 publications